|
1
|
Schreuders EH, Ruco A, Rabeneck L, Schoen
RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening:
A global overview of existing programmes. Gut. 64:1637–1649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mol L, Ottevanger PB, Koopman M and Punt
CJ: The prognostic value of WHO performance status in relation to
quality of life in advanced colorectal cancer patients. Eur J
Cancer. 66:138–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Wyk HC, Roxburgh CS, Horgan PG, Foulis
AF and McMillan DC: The detection and role of lymphatic and blood
vessel invasion in predicting survival in pa'tients with node
negative operable primary colorectal cancer. Crit Rev Oncol
Hematol. 90:77–90. 2014. View Article : Google Scholar
|
|
4
|
Ning Y and Lenz HJ: Targeting IL-8 in
colorectal cancer. Expert Opin Ther Targets. 16:491–497. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu M, Wang J, Tang W, Zhan X, Li Y, Peng
Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2
promotes proliferation, invasion and metastasis in colorectal
cancer. Oncogenesis. 5:e2712016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeong SH, Jeon YJ and Park SJ: Inhibitory
effects of dieckol on hypoxia-induced epithelial-mesenchymal
transition of HT29 human colorectal cancer cells. Mol Med Rep.
14:5148–5154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim BR, Kang MH, Kim JL, Na YJ, Park SH,
Lee SI, Kang S, Joung SY, Lee SY, Lee DH, et al: RUNX3 inhibits the
metastasis and angiogenesis of colorectal cancer. Oncol Rep.
36:2601–2608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi W, Ye Z, Zhuang L, Li Y, Shuai W, Zuo
Z, Mao X, Liu R, Wu J, Chen S and Huang W: Olfactomedin 1
negatively regulates NF-κB signalling and suppresses the growth and
metastasis of colorectal cancer cells. J Pathol. 240:352–365. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boudhraa Z, Bouchon B, Viallard C, D'Incan
M and Degoul F: Annexin A1 localization and its relevance to
cancer. Clin Sci. 130:205–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi H, Liu S, Guo C, Wang J, Greenaway FT
and Sun MZ: Role of Annexin A6 in cancer. Oncol Lett. 10:1947–1952.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lauritzen SP, Boye TL and Nylandsted J:
Annexins are instrumental for efficient plasma membrane repair in
cancer cells. Semin Cell Dev Biol. 45:32–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyoshi N, Yamamoto H, Mimori K, Yamashita
S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, et al:
ANXA9 gene expression in colorectal cancer: A novel marker for
prognosis. Oncol Lett. 8:2313–2317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bode AM, Dong Z and Wang H: Cancer
prevention and control: Alarming challenges in China. Natl Sci Rev.
3:117–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu J, Zhou Q, Xu J, Wang J and Zhang Y:
Detection of EGFR expression in patients with colorectal cancer and
the therapeutic effect of cetuximab. J BUON. 21:95–100.
2016.PubMed/NCBI
|
|
16
|
Bhopal RS: Diet and colorectal cancer
incidence. JAMA Intern Med. 175:1726–1727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114.
2016.PubMed/NCBI
|
|
18
|
Cai Z, Han S, Li Z, He L, Zhou J, Huang W
and Xu Y: A genome-wide assessment of variations of primary
colorectal cancer maintained in metastases. Gene. 595:18–24. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Xi Q and Wu G: Fatty acid synthase
regulates invasion and metastasis of colorectal cancer via Wnt
signaling pathway. Cancer Med. 5:1599–1606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou F, Mao R, Yang L, Lin S, Lei K, Zheng
Y, Ding Y, Zhang P, Cai G, Liang X and Liu J: Targeted deletion of
miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes
intestinal inflammation and colorectal cancer. FEBS J.
283:1438–1452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Z, Huang L, Zhao W and Rigas B:
Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and
inhibits its activation: Anticancer effects in vitro and in vivo.
Cancer Res. 70:2379–2388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang T, Peng H, Wang J, Yang J, Nice EC,
Xie K and Huang C: Prognostic and diagnostic significance of
Annexin A2 in colorectal cancer. Colorectal Dis. 15:e373–e381.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Boczonadi V and Määttä A: Annexin A9 is a
periplakin interacting partner in membrane-targeted cytoskeletal
linker protein complexes. FEBS Lett. 586:3090–3096. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goebeler V, Ruhe D, Gerke V and Rescher U:
Atypical properties displayed by annexin A9, a novel member of the
annexin family of Ca2+ and lipid binding proteins. FEBS
Lett. 546:359–364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Blanchot-Jossic F, Jarry A, Masson D,
Bach-Ngohou K, Paineau J, Denis MG, Laboisse CL and Mosnier JF:
Up-regulated expression of ADAM17 in human colon carcinoma:
Co-expression with EGFR in neoplastic and endothelial cells. J
Pathol. 207:156–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Das S, Czarnek M, Bzowska M, Mężyk-Kopeć
R, Stalińska K, Wyroba B, Sroka J, Jucha J, Deneka D, Stokłosa P,
et al: ADAM17 silencing in mouse colon carcinoma cells: The effect
on tumoricidal cytokines and angiogenesis. PLoS One. 7:e507912012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lima AI, Mota J, Monteiro SA and Ferreira
RM: Legume seeds and colorectal cancer revisited: Protease
inhibitors reduce MMP-9 activity and colon cancer cell migration.
Food Chem. 197:30–38. 2016. View Article : Google Scholar
|
|
28
|
Liu F, Zhang T, Zou S, Jiang B and Hua D:
B7-H3 promotes cell migration and invasion through the
Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. Mol Med
Rep. 12:5455–5460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weidle UH, Birzele F and Krüger A:
Molecular targets and pathways involved in liver metastasis of
colorectal cancer. Clin Exp Metastasis. 32:623–635. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Christensen IJ, Brünner N, Dowell B, Davis
G, Nielsen HJ, Newstead G and King D: Plasma TIMP-1 and CEA as
markers for detection of primary colorectal cancer: A prospective
validation study including symptomatic and non-symptomatic
individuals. Anticancer Res. 35:4935–4941. 2015.PubMed/NCBI
|
|
31
|
Nakayama H, Fukuda S, Inoue H,
Nishida-Fukuda H, Shirakata Y, Hashimoto K and Higashiyama S: Cell
surface annexins regulate ADAM-mediated ectodomain shedding of
proamphiregulin. Mol Biol Cell. 23:1964–1975. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou
HF, Guo L, Liu W, Wang SJ and Yu XG: ADAM17 targets MMP-2 and MMP-9
via EGFR-MEK-ERK pathway activation to promote prostate cancer cell
invasion. Int J Oncol. 40:1714–1724. 2012.
|
|
33
|
Li Q, Wang Y, Lai Y, Xu P and Yang Z:
HspB5 correlates with poor prognosis in colorectal cancer and
prompts epithelial-mesenchymal transition through ERK signaling.
PLoS One. 12:e01825882017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Iseki Y, Shibutani M, Maeda K, Nagahara H,
Ikeya T and Hirakawa K: Significance of E-cadherin and CD44
expression in patients with unresectble metastatic colorectal
cancer. Oncol Lett. 14:1025–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan X, Yan L, Liu S, Shan Z, Tian Y and
Jin Z: N-cadherin, a novel prognostic biomarker, drives malignant
progression of colorectal cancer. Mol Med Rep. 12:2999–3006. 2015.
View Article : Google Scholar : PubMed/NCBI
|
